title: Elevated atrial natriuretic peptides and early renal failure in type 2 diabetic Goto-Kakizaki rats.
abstract: The present investigation was designed to determine if atrial natriuretic peptides (ANPs) are increased in a spontaneous model of non-obese type 2 diabetes, the Goto-Kakizaki (GK) rat. Four peptide hormones originating from the ANP prohormone were increased twofold (P < .05) to sixfold (P < .01) in the circulation of GK rats compared with nondiabetic Wistar rats from which the GK colony was originally derived. Thus, ANP, long-acting natriuretic peptide (LANP), vessel dilator, and kaliuretic peptide were (mean +/- SE) 497 +/- 78, 1,285 +/- 105, 457 +/- 45, and 385 +/- 87 pg/mL in GK rats, versus 78 +/- 23, 542 +/- 77, 137 +/- 26, and 134 +/- 33 pg/mL, respectively, in Wistar rats. In evaluating the cause of the increased ANPs, the blood volume of GK rats (16.2 +/- 0.4 mL) was significantly (P < .01) increased compared with Wistar rats (9.5 +/- 0.3 mL). The ventricles of GK rats were not dilated when examined by transthoracic echocardiography, but the venous system was markedly distended. GK rats had a 48% to 79% decrease in renal function (ie, increased serum creatinine and blood urea nitrogen [BUN]) compared with Wistar rats. These results indicate that circulating ANPs are increased in the GK spontaneously diabetic rat secondary to (1) increased blood volume, which leads to increased synthesis and release of ANPs, and (2) renal failure, which results in a delayed metabolic processing of these peptides. The early combined increases of the four atrial peptides collectively may contribute to the hyperfiltration that occurs in early diabetes mellitus.
authors.affiliation: Department of Internal Medicine, James A. Haley Veterans Hospital and University of South Florida for Health Sciences, Tampa 33612, USA.
authors.forename: D L
authors.initials: DL
authors.lastname: Vesely
authors.forename: W R
authors.initials: WR
authors.lastname: Gower
authors.forename: J R
authors.initials: JR
authors.lastname: Dietz
authors.forename: R M
authors.initials: RM
authors.lastname: Overton
authors.forename: L C
authors.initials: LC
authors.lastname: Clark
authors.forename: E K
authors.initials: EK
authors.lastname: Antwi
authors.forename: R V
authors.initials: RV
authors.lastname: Farese
mesh_terms: D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood*; D001806:Blood Urea Nitrogen; D001810:Blood Volume; D003404:Creatinine / Q000097:blood; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D004452:Echocardiography; D006400:Hematocrit; D051379:Mice; D051381:Rats; D011919:Rats, Inbred Strains; D017208:Rats, Wistar; D051437:Renal Insufficiency / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D013997:Time Factors
chemical_list: D009320:Atrial Natriuretic Factor; D003404:Creatinine